Estimates Revisions Telix Pharmaceuticals Limited OTC Markets
Stocks
TLPP.F
AU000000TLX2
Biotechnology & Medical Research
|
Market Closed -
OTC Markets
12:22:36 2026-06-02 EDT
|
5-day change | 1st Jan Change | ||
| 9.000 USD | -15.49% |
|
-11.30% | +31.85% |
| 08-20 | Telix Pharmaceuticals Limited, H1 2026 Earnings Call, Aug 20, 2026 | |
| 08-19 | Telix Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- TLX Stock
- TLPP.F Stock
- Consensus Telix Pharmaceuticals Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
